Yi Xin Selected Research

Lung Neoplasms (Lung Cancer)

1/2021

Distinguishable Targeting of Non-Small Cell Lung Cancer Using Hyaluronan Functionalized Platinum Nanoclusters and Their Inhibition Behaviors of Proliferation, Invasion, Migration.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yi Xin Research Topics

Disease

15	Lung Injury 12/2023 - 02/2013
14	Inflammation (Inflammations) 11/2023 - 01/2015
14	Neoplasms (Cancer) 12/2021 - 10/2013
6	COVID-19 01/2023 - 01/2020
6	Tuberculosis (Tuberculoses) 04/2017 - 01/2008
6	Hepatocellular Carcinoma (Hepatoma) 03/2017 - 12/2012
5	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 12/2023 - 12/2014
4	Dysbiosis 09/2023 - 10/2017
4	Hypoxia (Hypoxemia) 01/2023 - 01/2017
4	Edema (Dropsy) 01/2022 - 12/2017
4	Acute Lung Injury 01/2021 - 01/2017
4	Pulmonary Atelectasis 01/2018 - 02/2011
4	Carcinogenesis 10/2017 - 10/2016
3	Pneumonia (Pneumonitis) 01/2023 - 01/2021
3	Obesity 09/2022 - 01/2020
3	Lung Diseases (Lung Disease) 01/2022 - 05/2012
3	Carcinoma (Carcinomatosis) 12/2021 - 05/2012
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 01/2019
3	Ventilator-Induced Lung Injury 01/2021 - 03/2015
3	Body Weight (Weight, Body) 01/2020 - 10/2015
3	Chronic Obstructive Pulmonary Disease (COPD) 01/2019 - 11/2014
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 03/2024 - 01/2015
2	Heart Failure 01/2022 - 10/2011
2	Emphysema 01/2022 - 01/2012
2	Insulin Resistance 01/2022 - 01/2021
2	Fatty Liver 01/2021 - 07/2017
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 07/2020 - 01/2019
2	Diabetes Mellitus 01/2018 - 02/2017
2	Hemorrhage 09/2016 - 01/2015
2	Sepsis (Septicemia) 01/2016 - 03/2015
2	Neoplasm Metastasis (Metastasis) 10/2013 - 12/2012
1	Emergence Delirium 04/2024
1	Venous Thrombosis (Deep-Vein Thrombosis) 03/2024
1	Pancreatitis 03/2024
1	Opportunistic Infections (Opportunistic Infection) 03/2024
1	Mucositis 11/2023
1	Colitis 09/2023
1	Apnea 05/2023
1	Overweight 01/2023

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 11/2023 - 01/2008
8	CytokinesIBA 01/2022 - 01/2015
6	Biomarkers (Surrogate Marker)IBA 01/2023 - 12/2012
5	Hydrochloric Acid (Hydrogen Chloride)FDA Link 12/2023 - 11/2020
4	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2015
4	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 02/2017
4	Pyruvic Acid (Pyruvate)IBA 11/2020 - 01/2017
3	Cisplatin (Platino)FDA LinkGeneric 11/2023 - 01/2019
3	Peptides (Polypeptides)IBA 09/2023 - 10/2014
3	Indicators and Reagents (Reagents)IBA 05/2023 - 01/2016
3	Oxygen (Dioxygen)IBA 01/2023 - 05/2012
3	Polysaccharides (Glycans)IBA 09/2022 - 12/2017
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 01/2016
3	Lactic Acid (Lactate)FDA LinkGeneric 11/2020 - 12/2017
3	EnzymesIBA 07/2017 - 01/2008
3	Caspase 3 (Caspase-3)IBA 01/2017 - 10/2016
3	Surface-Active Agents (Surfactants)IBA 02/2015 - 02/2013
2	NF-kappa B (NF-kB)IBA 09/2022 - 10/2016
2	InterleukinsIBA 01/2022 - 12/2017
2	Pancreatic Elastase (Elastase)IBA 01/2022 - 01/2012
2	PlatinumIBA 12/2021 - 01/2021
2	Oleic Acid (Oleate)IBA 01/2021 - 01/2021
2	Interleukin-10 (Interleukin 10)IBA 01/2021 - 01/2016
2	salicylhydroxamic acid (SHAM)IBA 11/2020 - 03/2015
2	N- (1,2,3,5,6,7- hexahydro- S- indacen- 4- ylcarbamoyl)- 4- (2- hydroxy- 2- propanyl)- 2- furansulfonamideIBA 07/2020 - 01/2019
2	Sirolimus (Rapamycin)FDA Link 07/2020 - 01/2019
2	Neuregulin-1 (Neuregulin 1)IBA 07/2020 - 01/2017
2	EndotoxinsIBA 01/2020 - 03/2015
2	AcidsIBA 11/2017 - 01/2017
2	HSP27 Heat-Shock ProteinsIBA 10/2017 - 10/2013
2	Dimenhydrinate (DMH)FDA LinkGeneric 10/2016 - 10/2016
2	Amino Acids FDA Link 06/2016 - 08/2012
2	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 01/2015 - 10/2013
2	Antitubercular AgentsIBA 05/2013 - 01/2008
1	CeruletideIBA 03/2024
1	Virulence Factors (Pathogenicity Factors)IBA 03/2024
1	RNA (Ribonucleic Acid)IBA 09/2023
1	Dextran SulfateIBA 09/2023
1	Drinking WaterIBA 09/2023
1	MucinsIBA 09/2023
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2023
1	Interferon alpha-2 (Roferon-A)FDA Link 01/2023
1	nitazoxanide (NTZ)FDA Link 01/2023
1	Sodium Bicarbonate (Baking Soda)FDA LinkGeneric 01/2023
1	fibrin fragment D (D-dimer)IBA 01/2023
1	leukocyte inhibitory factorIBA 01/2023
1	Sodium Chloride FDA LinkGeneric 01/2023
1	Mucin-2IBA 09/2022
1	Insulin Receptor Substrate ProteinsIBA 09/2022

Therapy/Procedure

12	Artificial Respiration (Mechanical Ventilation) 01/2023 - 02/2013
11	Therapeutics 12/2023 - 09/2012
7	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 12/2023 - 02/2011
4	Mechanical Ventilators (Ventilator) 01/2021 - 12/2014
2	Drug Therapy (Chemotherapy) 03/2024 - 01/2021
2	Intraperitoneal Injections 01/2021 - 08/2018
2	Renal Dialysis (Hemodialysis) 11/2020 - 01/2020
2	Oral Administration 01/2020 - 07/2019
2	Quantum Dots (Quantum Dot) 10/2019 - 08/2018
2	Semiconductors 10/2019 - 08/2018
2	Ligation 01/2017 - 03/2015
1	Anesthesia 04/2024